No Negative Psychological Impact Seen for Disclosing Aβ Status

Follow Drugslib on

Medically reviewed by Carmen Pope, BPharm. Last updated on May 9, 2025.

By Elana Gotkine HealthDay Reporter

FRIDAY, May 9, 2025 -- Disclosure of amyloid-β (Aβ) status seems not have a negative psychological impact, according to a study published online May 7 in Alzheimer's & Dementia.

Sapir Golan Shekhtman, from Sheba Medical Center in Ramat Gan, Israel, and colleagues examined emotional responses to Aβ status disclosure in cognitively normal individuals. To assess anxiety and depression associated with an elevated result, subjective memory complaints, and motivation for risk-reduction behavior, questionnaires were administered before and six months after disclosure of Aβ positron emission tomography (PET) results. Data were included for 199 cognitively normal adults.

The researchers observed reductions in all emotional parameters in association with nonelevated Aβ status disclosure relative to baseline. No changes in depression or memory complaints were seen in association with elevated Aβ disclosure, while there was a modest decrease in anxiety and motivation to change lifestyle.

"Our findings suggest no psychological harm in elevated and nonelevated Aβ PET scan status disclosure, strengthening findings from previous studies," the authors write. "The decrease in motivation to implement lifestyle changes after the disclosure of elevated or nonelevated Aβ status warns against false reassurance during the disclosure process."

Abstract/Full Text

Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.

Source: HealthDay

Posted : 2025-05-10 06:00

Read more

Disclaimer

Every effort has been made to ensure that the information provided by Drugslib.com is accurate, up-to-date, and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. Drugslib.com information has been compiled for use by healthcare practitioners and consumers in the United States and therefore Drugslib.com does not warrant that uses outside of the United States are appropriate, unless specifically indicated otherwise. Drugslib.com's drug information does not endorse drugs, diagnose patients or recommend therapy. Drugslib.com's drug information is an informational resource designed to assist licensed healthcare practitioners in caring for their patients and/or to serve consumers viewing this service as a supplement to, and not a substitute for, the expertise, skill, knowledge and judgment of healthcare practitioners.

The absence of a warning for a given drug or drug combination in no way should be construed to indicate that the drug or drug combination is safe, effective or appropriate for any given patient. Drugslib.com does not assume any responsibility for any aspect of healthcare administered with the aid of information Drugslib.com provides. The information contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.

Popular Keywords